News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski
May 4, 2025, 10:01

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CD56 expression modulates NAD+ metabolic landscape and may help predict sensitivity to anti-CD38 therapies and Isa-based regimens may provide comparable or even greater benefits than Dara-based regimens.”

Title: CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma

Authors: Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini, Daniela Fenoglio, Pamela Becherini, Andrea Benzi, Silvia Ravera, Isabella Traverso, Francesco Ladisa, Francesco Lai, Giulia Rivoli, Dario Truffelli, Aimable Nahimana, Antonia Cagnetta, Fabio Guolo, Chiara R. M. Uras, Anaïs Schavgoulidze, Jessica Fong Ng, Alessio Nencioni, Santina Bruzzone, Nikhil C. Munshi, Roberto Massimo Lemoli, Mariateresa Fulciniti and Michele Cea.

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

You can read the Full Article on Blood Cancer Journal.

More posts featuring Robert Orlowski.

Aimable Nahimana Alessio Nencioni Anaïs Schavgoulidze Andrea Benzi Antonia Cagnetta cancer Chiara R. M. Uras Daniela Fenoglio Dario Truffelli Debora Soncini Elena Maroto-Martin Fabio Guolo Francesco Ladisa Francesco Lai Giulia Giorgetti Giulia Rivoli Isabella Traverso Jessica Fong Ng Mariateresa Fulciniti Michele Cea multiple myeloma Myeloma Paper of the Day Nikhil C. Munshi OncoDaily Oncology Pamela Becherini Robert Orlowski Roberto Massimo Lemoli Santina Bruzzone Silvia Ravera
Special Coverage
Science
May 4, 2025, 10:01
Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski
Insight
May 4, 2025, 09:56
Catherine Alix-Panabières Will Present Her Latest Research on Circulating Tumor Cells in Immuno-Oncology at ISMRC 2025
Insight
May 4, 2025, 09:41
ICR Joins King Charles and Queen Camila at Buckingham Palace to Celebrate Cancer Awareness Initiatives
Insight
May 4, 2025, 09:25
Leo Cancer Care Particle Therapy Solution Marie is now 510(k) Pending
Blog
May 4, 2025, 09:15
Azra Raza and Aleksandra Filipovic Discuss Cancer Perspectives in 5th Episode of SPCC Interview
Science
May 4, 2025, 09:00
HER2 testing is evolving fast - Diego A. Díaz García
Insight
May 4, 2025, 08:54
Peter Pisters Marks Final Beam Placement with Giulio Draetta at MD Anderson's South Campus Research Expansion
Blog
May 4, 2025, 08:54
Ana Kreacic: Heading back to Milken Institute's Global Conference next week
Blog
May 4, 2025, 08:45
Michael Jefford: Quality cancer survivorship care - a modified Delphi study to define nurse capabilities
Blog
May 4, 2025, 08:40
ECO - Dégi László Csaba was pleased to be part of conferences ahead of 4th UN High-Level Meeting on NCDs and Mental Health
Science
May 4, 2025, 08:36
High-Grade Neuroendocrine Cancer Study Shared by Aman Chauhan
Societies
May 4, 2025, 08:32
STELLAR Phase III Trial Suggests Benefits of Short-Course Radiotherapy with Chemotherapy for Locally Advanced Rectal Cancer